Detalhe da pesquisa
1.
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).
Br J Haematol
; 204(4): 1243-1248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38083865
2.
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation.
Blood
; 139(7): 1066-1079, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699595
3.
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.
Blood
; 140(12): 1408-1418, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667047
4.
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia.
Haematologica
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299605
5.
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities.
Ann Hematol
; 103(1): 117-123, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030891
6.
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML.
Ann Hematol
; 103(6): 1941-1945, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634915
7.
CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.
Blood
; 137(16): 2209-2220, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512474
8.
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML.
Blood
; 137(24): 3390-3402, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33690800
9.
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia.
Am J Hematol
; 98(12): E360-E363, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705256
10.
Interpretation of ambiguous TP53 test results: Mosaicism, clonal hematopoiesis, and variants of uncertain significance.
J Genet Couns
; 2023 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715966
11.
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835307
12.
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia.
Curr Opin Hematol
; 29(1): 20-26, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854831
13.
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates.
Cancer
; 128(19): 3495-3501, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942592
14.
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Cancer
; 128(21): 3880-3887, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107670
15.
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes.
Br J Haematol
; 198(4): 713-720, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751140
16.
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype.
Blood
; 136(24): 2812-2823, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730593
17.
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
BMC Cancer
; 22(1): 1013, 2022 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153475
18.
Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomes.
Eur J Haematol
; 107(6): 609-616, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407254
19.
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
Blood
; 129(3): 358-370, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815262
20.
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
Blood
; 130(4): 397-407, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28576879